Darby Private Equity exits Symbiotec Pharmalab
Franklin Templeton Private Equity Strategy (FTPES), a fund advised by Darby Private Equity, has sold its equity holding in Symbiotec Pharmalab to private equity firm Actis. Symbiotec, based in Indore in Central India, is engaged in research, development, manufacturing and marketing of research based active pharmaceutical ingredients for corticosteroids and




